Genesis Capital back in clinical research with Crux Biolabs deal
It has cut a deal to take a controlling stake in the business, and existing owner Leading Technology Group will retain a minority position.
Source: afr.com
Stay updated with breaking news from Leading Technology Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It has cut a deal to take a controlling stake in the business, and existing owner Leading Technology Group will retain a minority position.
Crux Biolabs is a decade-old Australian leader in bioanalytics, customised biomarker detection, cell assay development, clinical and pre-clinical testing with...